What are the risks and benefits of using anticoagulation therapy for patients with atrial flutter?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18318949
Cited by: 0

Abstract

Anticoagulation in atrial flutter reduces stroke risk but includes bleeding risks, with DOACs often providing a safer, more effective profile than VKAs.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Venous Thromboembolism Diagnosis and Management

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
20 January 2026